ROSEN, A TOP RANKED LAW FIRM, Encourages PACS Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PACS

Core Viewpoint - Rosen Law Firm is reminding investors who purchased PACS Group Inc. common stock during its IPO and subsequent securities offerings about a class action lawsuit with a lead plaintiff deadline of January 13, 2025 [1][2]. Group 1: Class Action Details - Investors who bought PACS common stock during the IPO or the class period from April 11, 2024, to November 5, 2024, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. Group 2: Allegations Against PACS - The lawsuit alleges that PACS engaged in a scheme to submit false Medicare claims, which accounted for over 100% of its operating and net income from 2020 to 2023 [5]. - Additional claims include billing for unnecessary therapies to Medicare and falsifying documentation related to licensure and staffing, leading to materially misleading statements about PACS' business and operations [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].